Increased systemic IL-6 levels point to inflammation as a determinant of renal cell carcinoma development
Clin. biomed. res; 41 (3), 2021
Introduction: Renal cell carcinoma (RCC) is one of the most prevalent kidney tumors. Inflammation is believed to be a key factor in its progression and spread since inflammatory markers are generally associated with poor prognosis in RCC patients.
Cytokines are cell communication molecules involved in bo...